Anrikefon Injection for Postoperative Pain After Laparoscopic Gastrectomy in Gastric Cancer
Official title: Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy
Run by Tianjin Medical University Cancer Institute and Hospital · NCT07330063 · Data updated 2026-11-12
This trial tests whether Anrikefon given by IV can reduce pain after totally laparoscopic distal gastrectomy for gastric cancer.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 114 (estimated) |
| Sponsor | Tianjin Medical University Cancer Institute and Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Status | Recruiting |
| Started | April 8, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07330063 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 with gastric cancer scheduled for elective totally laparoscopic distal gastrectomy, ASA I–III, BMI 18–30, and who can receive PCIA.
✕Probably not a fit
Patients who do not respond to Anrikefon or those with contraindications to kappa agonists may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2, investigator-initiated trial evaluates the safety and efficacy of Anrikefon, a peripherally acting kappa opioid receptor agonist, for postoperative analgesia after total laparoscopic distal gastrectomy. Participants are adults with gastric cancer, undergoing elective surgery, and are randomized to receive Anrikefon either as an IV bolus or infusion or to placebo. The study will monitor pain scores, analgesic use, and adverse events to determine whether Anrikefon provides better pain relief with fewer central opioid-related side effects. The trial is conducted at Tianjin Medical University Cancer Institute and Hospital.
Why it matters
Potential benefit: If successful, patients may experience better pain control with fewer headaches, nausea, and sedation after surgery.
How similar studies have gone: Prior Phase 3 trials in other settings showed analgesic benefit with a favorable safety profile for Anrikefon and reduced PONV.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 75 years old (inclusive). * American Society of Anesthesiologists (ASA) physical status classification Class I-III. * Body Mass Index (BMI) ranging from 18 kg/m² to 30 kg/m² (inclusive). * Patients scheduled for elective total laparoscopic distal gastrectomy for gastric cancer under general anesthesia, with surgical duration \< 5 hours. * Surgical incision length \< 8 cm. * Voluntarily agree to participate in the trial and sign the informed consent form. Exclusion Criteria: * Patients undergoing emergency surgery or suffering from trauma. * Patients who undergo conversion to open surgery or laparoscopically assisted distal gastrectomy for gastric cancer during the operation. * Patients who refuse to receive Patient-Controlled Intravenous Analgesia (PCIA). * Patients with a history of prior abdominal surgery. * Patients expected to require prolonged endotracheal intubation after surgery.
Where it's running
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Principal investigator: Han Liang, MS — Tianjin Medical University Cancer Institute and Hospital
- Study coordinator: Bin Ke
- Email: binke@tmu.edu.cn
- Phone: 022-23340123-1061
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gastrocnemius plane block for foot and ankle surgery
This study tests whether a gastrocnemius plane block can reduce pain after foot and ankle surgery and lessen the use of opioid pain medicines in adults.
-
Quadroiliac Plane Block vs Transmuscular Quadratus Lumborum Block for Hip Replacement Pain
This study tests whether the Quadroiliac Plane Block provides better postoperative pain relief and lower opioid use than the transmuscular quadratus lumborum block after total hip arthroplasty conducted under spinal anesthesia.
-
Deep iliacus plane block vs transmuscular quadratus lumborum block for hip surgery pain relief
This study tests whether the deep iliacus plane block provides better pain relief and recovery than the transmuscular quadratus lumborum block after total hip replacement.
-
PIFPB-based blocks to aid pain relief after cardiac surgery
This observational study tests whether combining a pectoral-intercostal fascial plane block with either a recto-intercostal fascial plane block or a rectus sheath block can improve postoperative pain control for adults undergoing elective cardiac surgery.
-
Bilateral ESPB versus OSTAPB for postoperative pain after colorectal surgery
This study tests whether, after open colorectal surgery, an ultrasound-guided bilateral erector spinae plane block works better or the bilateral OSTAP block works better for controlling pain.
-
Comparing three ultrasound-guided nerve blocks to reduce pain after video-assisted thoracic surgery
This trial will try three ultrasound-guided regional blocks — paravertebral, intertransverse process, and erector spinae plane — to see which best lowers opioid use and pain after elective VATS in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.